| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 321.19M | — |
| Operating expense | — | — |
| Net income | 54.62M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TE1.F returned +28.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +25.1% |
| 1 year | +28.9% |
| 5 years | -40.8% |
| 10 years | +183.1% |
| All-time high | €109.50 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in TE1.F would be worth today ›Yes. Bio-Techne Corporation paid 4 dividends over the past 12 months. The most recent was €0.07 per share on Aug 24, 2026. The dividend yield is 0.44%.
Bio-Techne Corporation is part of the Healthcare sector.
Bio-Techne Corporation has a market cap of 9.62B EUR, based on the latest quote.
Bio-Techne Corporation is expected to report earnings around Nov 9, 2026. That date is an estimate and has not been confirmed by the company.
